Point72 Hong Kong LTD Kal Vista Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $21,591 - $39,954	2,646 New	2,646 $26,000
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $11,256 - $17,054	-1,005 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $12,421 - $18,371	1,005 New	1,005 $13,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $1,464 - $2,529	-142 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$11.6 - $21.67 $1,647 - $3,077	142 New	142 $2,000

126

47.9M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $217M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.